Valneva Publishes Findings on Chikungunya Impact in British Medical Journal

Valneva SE announced the publication of a study in The British Medical Journal analyzing the global health and economic impact of chikungunya from 2011 to 2020. The study highlights a broader disease burden and significant costs associated with chikungunya, which could strain health systems due to its unpredictable nature.

The analysis revealed 18.7 million reported cases in 110 countries, leading to 1.95 million disability-adjusted life years lost. The financial impact reached $2.8 billion in direct costs and $47.1 billion in indirect expenses, with the majority of cases in Latin America and the Caribbean.

Climate change is contributing to year-round mosquito-borne disease threats, potentially increasing chikungunya outbreaks. WHO has marked chikungunya as a major public health concern. Valneva underscores the necessity for these insights to guide prevention and response strategies worldwide.